Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cohesion's CoStasis Surgical Hemostat To Ship In July, Gains FDA Approval

This article was originally published in The Gray Sheet

Executive Summary

Tyco International's U.S. Surgical unit will market Cohesion Technologies' CoStasis liquid surgical hemostat. Shipments are expected to begin in early July.

You may also be interested in...



Fusion Shipping FloSeal Hemostatic Sealant Following Dec. 8 FDA Approval

Fusion Medical Technologies commenced shipments of its FloSeal hemostatic sealant on Dec. 9 at a price of $125 for a 4 ml kit, following FDA approval Dec. 8.

CoStasis Stops Bleeding At Hard And Soft Tissue Sites - Cohesion PMA Study

Cohesion Technologies plans to file a premarket approval application this spring for its CoStasis surgical hemostat for treatment of bleeding in cardiovascular, hepatic, general and orthopedic surgery procedures, the firm announced Jan. 14.

Biden Extends Helping Hand To Small US Manufacturers, Vendors With ‘Made In America’ EO

The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel